Navigation Links
Former Head of UK Medicines & Healthcare Products Regulatory Agency (MHRA) Sir Alasdair Breckenridge Joins NDA Partners
Date:8/14/2013

Madison, VA (PRWEB) August 14, 2013

Carl Peck, MD, Chairman of NDA Partners LLC (NDAP), today announced that Sir Alasdair Breckenridge, former head of the UK Medicines & Healthcare Products Regulatory Agency (MHRA) has joined NDA Partners as a partner in the firm. MHRA is the Department of Health agency responsible for regulating all medicines and medical devices marketed in the UK.

In his role at NDA Partners, Sir Alasdair will provide leadership for the firm’s expanding EU operations and expert consulting to its worldwide client base in complex and rapidly evolving topics such as health care policy, health technology assessment, reimbursements, EU clinical trials, global product development, global regulatory strategies, benefit-risk assessment, and bioethics. “Alasdair’s decades of experience at the forefront of drug development science and deep understanding of the global regulatory environment will be a tremendous asset for our clients as they seek the best available advice to guide their development programs”, said Dr Peck. “We look forward to Alasdair’s active involvement on our team and with our global client base”.

Sir Alasdair has a long and prestigious career in drug development science and regulatory affairs. He was the first Chair of MHRA when it was formed in 2003 and retained this position until his retirement from the Agency in 2012. During his tenure at MHRA, he served as the first Chair of the Department of Health's Emerging Science and Bioethics Advisory Committee (ESBAC), an organization responsible for providing advice to UK health departments on emerging healthcare scientific developments and their ethical, legal, social and economic implications. He was a member of the Medical Research Council, worked closely on several programs of the European Union, the World Health Organization and the International Union of Pharmacology, and was Chair of the Committee on Safety of Medicines. Prior to MHRA, he was Professor of Clinical Pharmacology at the University of Liverpool and a member and then Chairman of local and regional health authorities in the north-west of England, including Chairman of the North West Regional Office. Sir Alasdair is a clinical pharmacologist and after training at the Royal Postgraduate Medical School, he was appointed to the Chair of Clinical Pharmacology at the University of Liverpool. Sir Alasdair was knighted in 2004.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11018273.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
2. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
3. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
4. PharmaVentures Helps Secure Investor for Former MSD Research Site
5. Dr. Michael Yaremchuk, Leading Performer of Custom-Designed Facial Implants, Pioneers Bespoke Plastic Surgery
6. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
7. Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin
8. Former Stryker CEO Takes Reins at sBioMed
9. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
10. Non-Intrusive Black Mold Removal Procedure Released By Former Mold Remediation Specialist, MyCleaningProducts.com Explains
11. Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... ... Supplyframe, the Industry Network for electronics hardware design and ... in Pasadena, Calif., the Design Lab’s mission is to bring together inventors and ... brought to market. , The Design Lab is Supplyframe’s physical representation of one ...
Breaking Biology Technology:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
Breaking Biology News(10 mins):